Omnicell OMCL
NASDAQ OMCL
$34.37 -0.45 (-1.29%)
At close: Sep 4, 2026 · 4:00 PM EDT

Omnicell (OMCL) Change in Account Payables (2010 - 2026)

Omnicell's (OMCL) quarterly Change in Account Payables came in at -$8.9 million in Q2 2026, down 191.6% year-over-year from $9.8 million in Q2 2025, and down 155.25% quarter-over-quarter from $16.2 million in Q1 2026.

Analysis

Omnicell (OMCL) Change in Account Payables (2010 - 2026) Analysis & Trends

Omnicell (OMCL) has reported Change in Account Payables for 17 consecutive years, with -$8.9 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Change in Account Payables fell 191.6% year-over-year to -$8.9 million in Q2 2026; TTM through Jun 2026 was -$12.7 million, a 196.85% decrease from a year earlier, with the FY2025 full-year figure at -$9.3 million, down 228.75% from the prior year.
  • Change in Account Payables was -$8.9 million for Q2 2026 at Omnicell, down from $16.2 million in the prior quarter.
  • Over five years, Change in Account Payables peaked at $16.2 million in Q1 2026 and troughed at -$20.0 million in Q4 2025.
  • A 5-year average of -$1.1 million and a median of $13000.0 in 2023 frame the typical range for Change in Account Payables.
  • Across the five-year window, Change in Account Payables tumbled 7315.0% in 2024 and surged 1637.49% in 2026, its largest moves.
  • Over 5 years, Change in Account Payables stood at -$9.8 million in 2022, then surged by 57.47% to -$4.2 million in 2023, then surged by 202.35% to $4.3 million in 2024, then plunged by 568.42% to -$20.0 million in 2025, then soared by 55.26% to -$8.9 million in 2026.
  • The last three Change in Account Payables figures came in at -$8.9 million (Q2 2026), $16.2 million (Q1 2026), and -$20.0 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn -
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn -52.50 Mn
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn -
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn 71.00 Mn
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn -
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn -
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn -
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn -
9 Resmed 32.94 Bn 31.47 Bn 861.22 Mn -
10 Omnicell 1.57 Bn 1.28 Bn 152.94 Mn -8.94 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -8.94 Mn
Mar 31, 2026 16.18 Mn
Dec 31, 2025 -19.98 Mn
Sep 30, 2025 6,000.00
Jun 30, 2025 9.76 Mn
Mar 31, 2025 931,000.00
Dec 31, 2024 4.27 Mn
Sep 30, 2024 -1.81 Mn
Jun 30, 2024 6.19 Mn
Mar 31, 2024 -1.44 Mn
Dec 31, 2023 -4.17 Mn
Sep 30, 2023 2.45 Mn
Jun 30, 2023 -15.83 Mn
Mar 31, 2023 20,000.00
Dec 31, 2022 -9.80 Mn
Sep 30, 2022 5.17 Mn
Jun 30, 2022 -3.44 Mn
Mar 31, 2022 312,000.00
Dec 31, 2021 -4.03 Mn
Sep 30, 2021 17.43 Mn